Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective Longitudinal Study of CA 19-9 as an Aid in Monitoring Disease in Patients With Pancreatic Cancer

NCT02250638 is registered in ClinicalTrials.gov with Fujirebio Diagnostics, Inc. as lead sponsor.

NCT NCT02250638
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02250638 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective Longitudinal Study of CA 19-9 as an Aid in Monitoring Disease in Patients With Pancreatic Cancer
Lead sponsor
Fujirebio Diagnostics, Inc.
Phase
Observational
Overall status
Completed
Start date
May 31, 2014
Completion date
June 30, 2021
Enrollment
140 (estimated)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

pancreatic cancer